Harvard Apparatus Regenerative Technology Inc. HRGN
Set alert
2.30 USD +0.14 +6.48%
At close · Oct 30
2.23 Day range 2.30
1.00 52-week range 2.35
- YTD
- +25.00%
- 1 year
- +19.17%
- Open
- 2.24
- Prev close
- 2.16
- Mkt cap
- 46.65M
- Vol
- 1.80K
- Avg vol
- 1.59K
- EPS
- -0.39
- P/E
- 0.00
More statistics
- Low
- 2.23
- High
- 2.30
2Y chart
Signals (107)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| RSI: Overbought | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| RSI: Oversold | Aug 3, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| RSI: Oversold | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 28, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 22, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 8, 2026 | 6 months ago |
| RSI: Oversold | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Feb 13, 2026 | 8 months ago |
| SMA: Bearish | Feb 13, 2026 | 8 months ago |
| SMA: Bullish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Jan 30, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| RSI: Oversold | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 9 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 23, 2025 | 10 months ago |
| SMA: Bearish | Dec 18, 2025 | 10 months ago |
| SMA: Bullish | Dec 16, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 5, 2025 | 11 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| SMA: Bullish | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 13, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 17, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 2, 2025 | 1 year ago |
| SMA: Bearish | Aug 29, 2025 | 1 year ago |
| RSI: Overbought | Aug 25, 2025 | 1 year ago |
| RSI: Overbought | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 18, 2025 | 1 year ago |
| RSI: Oversold | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| RSI: Oversold | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| RSI: Oversold | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| RSI: Oversold | Mar 28, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 27, 2025 | 1 year ago |
| RSI: Oversold | Mar 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 19, 2025 | 1 year ago |
| SMA: Bearish | Feb 13, 2025 | 1 year ago |
| SMA: Bullish | Feb 11, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 4, 2025 | 1 year ago |
| SMA: Bearish | Jan 28, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 23, 2025 | 1 year ago |
| RSI: Oversold | Dec 2, 2024 | 1 year ago |
Financials — quick view
HRGN Revenue — quarterly 0
HRGN Net income — quarterly -2.61M
HRGN EPS — quarterly -0.19
News
- Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic
- Harvard Apparatus Regenerative Technology Collaborates with University of Southern California to Test Treatment for Esophageal Disease
- Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)
- Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children's Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia
- Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
- Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
- Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
- Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy
- Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaboration to Repair and Regenerate the Uterus
Your note
Sign in to keep a note on HRGN — it syncs with the Stock Master app.